Cargando…
Chronic bronchial infection in COPD. Is there an infective phenotype?
Microorganisms, particularly bacteria, are frequently found in the lower airways of COPD patients, both in stable state and during exacerbations. The host–pathogen relationship in COPD is a complex, dynamic process characterised by frequent changes in pathogens, their strains and loads, and subseque...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126218/ https://www.ncbi.nlm.nih.gov/pubmed/23218452 http://dx.doi.org/10.1016/j.rmed.2012.10.024 |
_version_ | 1783516100918509568 |
---|---|
author | Matkovic, Zinka Miravitlles, Marc |
author_facet | Matkovic, Zinka Miravitlles, Marc |
author_sort | Matkovic, Zinka |
collection | PubMed |
description | Microorganisms, particularly bacteria, are frequently found in the lower airways of COPD patients, both in stable state and during exacerbations. The host–pathogen relationship in COPD is a complex, dynamic process characterised by frequent changes in pathogens, their strains and loads, and subsequent host immune responses. Exacerbations are detrimental events in the course of COPD and evidence suggests that 70% may be caused by microorganisms. When considering bacterial exacerbations, recent findings based on molecular typing have demonstrated that the acquisition of new strains of bacteria or antigenic changes in pre-existing strains are the most important triggers for exacerbation onset. Even in clinically stable COPD patients the presence of microorganisms in their lower airways may cause harmful effects and induce chronic low-grade airway inflammation leading to increased exacerbation frequency, an accelerated decline in lung function and impaired health-related quality of life. Besides intraluminal localisation in the distal airways, bacteria can be found in the bronchial walls and parenchymal lung tissue of COPD patients. Therefore, the isolation of pathogenic bacteria in stable COPD should be considered as a form of chronic infection rather than colonisation. This new approach may have important implications for the management of patients with COPD. |
format | Online Article Text |
id | pubmed-7126218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71262182020-04-08 Chronic bronchial infection in COPD. Is there an infective phenotype? Matkovic, Zinka Miravitlles, Marc Respir Med Review Microorganisms, particularly bacteria, are frequently found in the lower airways of COPD patients, both in stable state and during exacerbations. The host–pathogen relationship in COPD is a complex, dynamic process characterised by frequent changes in pathogens, their strains and loads, and subsequent host immune responses. Exacerbations are detrimental events in the course of COPD and evidence suggests that 70% may be caused by microorganisms. When considering bacterial exacerbations, recent findings based on molecular typing have demonstrated that the acquisition of new strains of bacteria or antigenic changes in pre-existing strains are the most important triggers for exacerbation onset. Even in clinically stable COPD patients the presence of microorganisms in their lower airways may cause harmful effects and induce chronic low-grade airway inflammation leading to increased exacerbation frequency, an accelerated decline in lung function and impaired health-related quality of life. Besides intraluminal localisation in the distal airways, bacteria can be found in the bronchial walls and parenchymal lung tissue of COPD patients. Therefore, the isolation of pathogenic bacteria in stable COPD should be considered as a form of chronic infection rather than colonisation. This new approach may have important implications for the management of patients with COPD. Elsevier Ltd. 2013-01 2012-12-04 /pmc/articles/PMC7126218/ /pubmed/23218452 http://dx.doi.org/10.1016/j.rmed.2012.10.024 Text en Copyright © 2012 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Matkovic, Zinka Miravitlles, Marc Chronic bronchial infection in COPD. Is there an infective phenotype? |
title | Chronic bronchial infection in COPD. Is there an infective phenotype? |
title_full | Chronic bronchial infection in COPD. Is there an infective phenotype? |
title_fullStr | Chronic bronchial infection in COPD. Is there an infective phenotype? |
title_full_unstemmed | Chronic bronchial infection in COPD. Is there an infective phenotype? |
title_short | Chronic bronchial infection in COPD. Is there an infective phenotype? |
title_sort | chronic bronchial infection in copd. is there an infective phenotype? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126218/ https://www.ncbi.nlm.nih.gov/pubmed/23218452 http://dx.doi.org/10.1016/j.rmed.2012.10.024 |
work_keys_str_mv | AT matkoviczinka chronicbronchialinfectionincopdisthereaninfectivephenotype AT miravitllesmarc chronicbronchialinfectionincopdisthereaninfectivephenotype |